Wilson Sonsini Goodrich & Rosati represented 6 Dimensions and VFLO in this transaction. Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati is representing LENZ Therapeutics in the transaction, Goodwin Procter is representing Graphite Bio and Latham & Watkins is representing the placements...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Idorsia in the transaction. Idorsia Ltd (SIX:IDIA) announced that it entered into an agreement with Janssen Biotech Inc., one of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Alto Neuroscience on the deal. Alto Neuroscience announced the closing of a $35 million Series B financing led by Lightswitch...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Metacrine on the deal. Equillium, Inc. and Metacrine Inc. announced that the two companies have entered into a definitive merger agreement pursuant to...
You must be a Standard 1 Year member to access this content.
